The VeriSeq PGS Kit takes advantage of next-generation sequencing (NGS) technology to provide comprehensive, accurate screening of all 24 chromosomes for selection of euploid embryos. Preimplantation genetic screening (PGS) results generated using VeriSeq PGS are comparable to those achieved with the widely used array-based 24sure technology. In addition, NGS offers the opportunity for improved assay workflow, higher throughput, and enhanced performance.
NGS offers a highly sensitive method for screening embryos, requiring as little as 1 ng of DNA from a SurePlex DNA amplification reaction. DNA can be obtained from a blastomere biopsy from a day 3 embryo or from a trophectodermal (TE) biopsy from a blastocyst.
The VeriSeq PGS Kit includes everything needed for PGS using Illumina NGS technology in a single kit:
For research use only. Not for in vitro diagnostic use.
|Description||Document Type||File Info|
|VeriSeq PGS Kit - MiSeq System Product Information Sheet||Product Information Sheet||PDF< 1 MB|
|VeriSeq PGS Solution on the MiSeq System||Data Sheet||PDF< 1 MB|
|VeriSeq NIPT Analysis Software (16 Samples)||Data Sheet||PDF< 1 MB|
Catalog IDs: RH-101-1001